Sign up for free insights newsletter
EN

Enlitic Inc

ENLAustralian Securities Exchange

Need professional-grade analysis? Visit stockanalysis.com

A$0.01
+11.11%
End of day
Market Cap

$8.33M

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino0.0084.60-0.71-0.83-0.8810.62
Calmar0.00-1.36-1.07-0.91-0.99
Sharpe0.0035.25-0.43-0.51-0.554.29
Omega1.112.080.980.920.921.10
Martin0.00-1.92-1.59-1.46-1.49
Ulcer5.008.3744.1454.9855.0043.27

Enlitic Inc (ENL) Price Performance

Enlitic Inc (ENL) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at AUD0.01, up 11.11% from the previous close.

Over the past year, ENL has traded between a low of AUD0.01 and a high of AUD0.05. The stock has lost 79.2% over this period. It is currently 80.6% below its 52-week high.

Enlitic Inc has a market capitalization of $8.33M.

About Enlitic Inc

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.

Compare Enlitic Inc

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
Australian Securities Exchange
Currency
AUD
Country
Australia

Financial Metrics

Revenue (TTM)
$3.80M
EBITDA
$-12,707,180
Profit Margin
-349.07%
EPS (TTM)
-0.03
Book Value
0.01

Technical Indicators

52 Week High
A$0.05
52 Week Low
A$0.01
50 Day MA
A$0.01
200 Day MA
A$0.02
Beta
-1.59

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
2.19
Price/Book
1.45
Enterprise Value
$5.97M